Novilytic is a biochemistry analytics company that protects and secures lifesaving drugs and medical devices.
Our potency is extended by our people which includes 5 Ph.D. Chemists and Engineers who have helped us secure significant patents and other IP. Our business plan will increase those forces to insure we meet customer, market, and regulatory demands.
“The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies.
Eugene L. Inman, Ph.D.
Pharmaceutical Quality Consultant
Retired Eli Lilly and Company
“Novalytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.”
Martin Long, BSc.
Analytical Sciences Business – Past GM
(Brooks Life Sciences, Thermo, Perkin Elmer)
“We couldn’t be more thrilled by the results of our validation and stability analyses using the NoviPlex dry plasma cards and look forward to using them in our DMD clinical trial.”
Ines Macias-Perez, Ph.D
Principle Scientist, Product Development
20 - 50
Proteoforms in Each
The Proteometer Detects them All!